Letrozole Tablets Application Scope

Letrozole Tablets are used for the treatment of postmenopausal patients with advanced breast cancer who have failed anti-estrogen therapy.

letrozole tablets

Features of Letrozole Tablets

Ingredient: Letrozole

Characteristics: Treatment of advanced breast cancer

Specification: 2.5 mg

Packing size: 10*2.5mg

Storage: 2°C to 8°C (36°F to 46°F). Do not freeze. Avoid light.

Expiry date: 36 months

Approval number: State Drug License H19991001

Revision date According to the latest drug insert.

Manufacturer: Jiangsu Hengrui Medicine Co.

Letrozole Tablets User Guide

Dosage and administration: Oral, 2.5mg (1 tablet) each time, once a day. No dosage adjustment is required for elderly patients, patients with mild to moderate hepatic impairment, and creatinine clearance ≥10 ml/min.

Adverse reactions: skeletal muscle pain, nausea, headache, joint pain, fatigue, dyspnea, cough, constipation, vomiting, diarrhea, chest pain, viral infections, facial flushing, and abdominal pain.

Letrozole Tablets Restrictions

Contraindications: It is contraindicated for those who are allergic to this product and its excipients. Pre-menopausal women should be cautious. Use with caution in severe hepatic and renal impairment.
Precautions: Be aware of the potential danger of this product to the fetus. Abnormal liver biochemical parameters have been observed in a few patients and are not associated with liver metastases. Differences in letrozole pharmacokinetics between adults and children have not been studied.

Letrozole Tablet Interactions

The interaction of Letrozole Tablet with other drugs has not been determined. Before starting treatment, inform your doctor of all medications you are using.

Note: If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYueMed.

It is only for internal discussion among medical staff and does not serve as a basis for medication. For specific medication guidelines, please consult the attending physician.